Clinical Trials Browser

Phase 1/2 × Tosylarginine Methyl Ester × 90 days × Clear all

NCT03953326 2026-02-27

HeartPhone Cancer Survivors Trial 2019

Phase 1/2 Terminated

2 enrolled 6 charts

BreastLymphoidOther hematologic neoplasm

Breast Neoplasms, Leukemia, Lymphoma